Cargando…

Immunovirotherapy for glioblastoma

Detalles Bibliográficos
Autores principales: Ning, Jianfang, Wakimoto, Hiroaki, Rabkin, Samuel D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3906230/
https://www.ncbi.nlm.nih.gov/pubmed/24241205
http://dx.doi.org/10.4161/cc.27039
_version_ 1782301463369744384
author Ning, Jianfang
Wakimoto, Hiroaki
Rabkin, Samuel D
author_facet Ning, Jianfang
Wakimoto, Hiroaki
Rabkin, Samuel D
author_sort Ning, Jianfang
collection PubMed
description
format Online
Article
Text
id pubmed-3906230
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Landes Bioscience
record_format MEDLINE/PubMed
spelling pubmed-39062302014-02-04 Immunovirotherapy for glioblastoma Ning, Jianfang Wakimoto, Hiroaki Rabkin, Samuel D Cell Cycle Editorials: Cell Cycle Features Landes Bioscience 2014-01-15 2013-11-14 /pmc/articles/PMC3906230/ /pubmed/24241205 http://dx.doi.org/10.4161/cc.27039 Text en Copyright © 2014 Landes Bioscience http://creativecommons.org/licenses/by-nc/3.0/ This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited.
spellingShingle Editorials: Cell Cycle Features
Ning, Jianfang
Wakimoto, Hiroaki
Rabkin, Samuel D
Immunovirotherapy for glioblastoma
title Immunovirotherapy for glioblastoma
title_full Immunovirotherapy for glioblastoma
title_fullStr Immunovirotherapy for glioblastoma
title_full_unstemmed Immunovirotherapy for glioblastoma
title_short Immunovirotherapy for glioblastoma
title_sort immunovirotherapy for glioblastoma
topic Editorials: Cell Cycle Features
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3906230/
https://www.ncbi.nlm.nih.gov/pubmed/24241205
http://dx.doi.org/10.4161/cc.27039
work_keys_str_mv AT ningjianfang immunovirotherapyforglioblastoma
AT wakimotohiroaki immunovirotherapyforglioblastoma
AT rabkinsamueld immunovirotherapyforglioblastoma